{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:17:08Z","timestamp":1791526628159,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.phymed.2016.10.013","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T14:30:15Z","timestamp":1477319415000},"page":"1699-1705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7250-8960","authenticated-orcid":false,"given":"John R","family":"Keefe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun J","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Soeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing S","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D","family":"Amsterdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2016.10.013_bib0066","unstructured":"American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision. Washington, DC: American Psychiatric Association; 476."},{"key":"10.1016\/j.phymed.2016.10.013_bib0001","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/JCP.0b013e3181ac935c","article-title":"A randomized, double-blind, placebo-controlled trial of oral matricaria recutita (chamomile) extract therapy for generalized anxiety disorder","volume":"29","author":"Amsterdam","year":"2009","journal-title":"J. Clin. Psychopharmacol"},{"key":"10.1016\/j.phymed.2016.10.013_bib0002","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"Ashton","year":"2005","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0003","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/NMD.0b013e3181ea169f","article-title":"A cross-ethnic comparison of lifetime prevalence rates of anxiety disorders","volume":"198","author":"Asnaani","year":"2010","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.phymed.2016.10.013_bib0004","first-page":"S177","article-title":"Benzodiazepine-like compounds and GABA in flower heads of matricaria chamomilla","volume":"10","author":"Avallone","year":"1995","journal-title":"Phytoth. Res."},{"key":"10.1016\/j.phymed.2016.10.013_bib0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1139\/Y07-083","article-title":"Effects of traditionally used anxiolytic botanicals on enzymes of the gamma-aminobutyric acid (GABA) system","volume":"85","author":"Awad","year":"2007","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phymed.2016.10.013_bib0006","doi-asserted-by":"crossref","first-page":"d1199","DOI":"10.1136\/bmj.d1199","article-title":"Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis","volume":"342","author":"Baldwin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2016.10.013_bib0007","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3109\/15622975.2011.624548","article-title":"An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder","volume":"13","author":"Baldwin","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0008","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use","volume":"18","author":"Barker","year":"2004","journal-title":"Cns Drugs"},{"key":"10.1016\/j.phymed.2016.10.013_bib0009","doi-asserted-by":"crossref","unstructured":"Bates, D., Maechler, M., Bolker, B., Walker, S., Christensen, R.H.B., Singmann, H., Dai, B., Grothendieck, G., Green, P., 2016. lme4: Linear Mixed-Effects Models Using 'Eigen' and S4, 1.1-12 ed.","DOI":"10.18637\/jss.v067.i01"},{"key":"10.1016\/j.phymed.2016.10.013_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1381612023396681","article-title":"Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal","volume":"8","author":"Bateson","year":"2002","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.phymed.2016.10.013_bib0011","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.phymed.2016.10.013_bib0012","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.euroneuro.2003.08.002","article-title":"Molecular mechanisms of tolerance to and withdrawal of GABA(A) receptor modulators","volume":"13","author":"Biggio","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phymed.2016.10.013_bib0013","article-title":"The complete commission E monographs: therapeutic guide to herbal medicines","author":"Blumenthal","year":"1998","journal-title":"Int. Med. Commun."},{"key":"10.1016\/j.phymed.2016.10.013_bib0014","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0028-3908(02)00012-6","article-title":"Tolerance to the sedative effect of lorazepam correlates with a diminution in cortical release and affinity for glutamate","volume":"42","author":"Bonavita","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phymed.2016.10.013_bib0015","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/appi.ajp.162.6.1179","article-title":"Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study","volume":"162","author":"Bruce","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0016","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-8741(97)00055-X","article-title":"Quantitative ethnopharmacological study of the Campidano Valley and Urzulei district","volume":"57","author":"Bruni","year":"1997","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2016.10.013_bib0017","article-title":"Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs","volume":"12","author":"Davidson","year":"2010","journal-title":"Prim. Care. Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0367-326X(01)00362-8","article-title":"Medicinal plants popularly used in the Brazilian tropical Atlantic forest","volume":"73","author":"Di Stasi","year":"2002","journal-title":"Fitoterapia"},{"key":"10.1016\/j.phymed.2016.10.013_bib0019","first-page":"309","article-title":"Clinical management\u2013imipramine\/placebo administration manual","volume":"23","author":"Fawcett","year":"1987","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.phymed.2016.10.013_bib0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/PCC.v03n0105","article-title":"SSRI antidepressant medications: adverse effects and tolerability","volume":"3","author":"Ferguson","year":"2001","journal-title":"Prim Care. Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0021","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID-I\/P W\/PSY Screen)","author":"First","year":"2001"},{"key":"10.1016\/j.phymed.2016.10.013_bib0022","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/da.20919","article-title":"The impact of stressful life events on relapse of generalized anxiety disorder","volume":"29","author":"Francis","year":"2012","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.phymed.2016.10.013_bib0023","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1001\/jama.283.23.3082","article-title":"Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6-month randomized controlled trial","volume":"283","author":"Gelenberg","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.phymed.2016.10.013_bib0024","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/jcp.0b013e31815152a5","article-title":"Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence","volume":"27","author":"Goethe","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.phymed.2016.10.013_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.phymed.2016.10.013_bib0026","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1476-5381.2011.01228.x","article-title":"Flavonoid modulation of GABA(A) receptors","volume":"163","author":"Hanrahan","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2016.10.013_bib0027","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1176\/ajp.155.1.62","article-title":"Patterns and predictors of treatment contact after first onset of psychiatric disorders","volume":"155","author":"Kessler","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0028","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int. J. Meth. Psychiatr. Res."},{"key":"10.1016\/j.phymed.2016.10.013_bib0029","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1176\/appi.ajp.158.2.289","article-title":"The use of complementary and alternative therapies to treat anxiety and depression in the United States","volume":"158","author":"Kessler","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1192\/bjp.bp.107.039966","article-title":"Prevalence of common mental disorders in general practice attendees across Europe","volume":"192","author":"King","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0031","unstructured":"Kuznetsova, A., Brockhoff, P.B., Christensen, R.H.B., 2016. lmerTest: Tests in Linear Mixed Effects Models, 2.0-30 ed."},{"key":"10.1016\/j.phymed.2016.10.013_bib0032","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2014will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.phymed.2016.10.013_bib0033","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(96)00486-4","article-title":"Involvement of monoamine oxidase and noradrenaline uptake in the positive chronotropic effects of apigenin in rat atria","volume":"312","author":"Lorenzo","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2016.10.013_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2016.10.012","article-title":"Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial","author":"Mao","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2016.10.013_bib0034","first-page":"5","article-title":"Long-term chamomile therapy of generalized anxiety disorder: a study protocol for a randomized, double-blind, placebo-controlled trial","volume":"4","author":"Mao","year":"2014","journal-title":"Clinical Trials"},{"key":"10.1016\/j.phymed.2016.10.013_bib0035","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/1568026023393462","article-title":"GABA(A)-receptor ligands of flavonoid structure","volume":"2","author":"Marder","year":"2002","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/j.phymed.2016.10.013_bib0036","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4088\/JCP.12r07757","article-title":"Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review","volume":"74","author":"McHugh","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0037","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12906-016-1022-3","article-title":"Herbal medicine use behaviour in Australian adults who experience anxiety: a descriptive study","volume":"16","author":"McIntyre","year":"2016","journal-title":"BMC Complement Altern. Med."},{"key":"10.1016\/j.phymed.2016.10.013_bib0038","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0367-326X(00)00139-8","article-title":"Contribution to the knowledge of Rifian traditional medicine. II: folk medicine in Ksar Lakbir district (NW Morocco)","volume":"71","author":"Merzouki","year":"2000","journal-title":"Fitoterapia"},{"key":"10.1016\/j.phymed.2016.10.013_bib0039","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.jcp.0000155821.74832.f9","article-title":"A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder","volume":"25","author":"Mitte","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.phymed.2016.10.013_bib0040","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1248\/bpb.26.474","article-title":"Antidepressant-like effects of apigenin and 2,4,5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test","volume":"26","author":"Nakazawa","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2016.10.013_bib0041","first-page":"1069","article-title":"Treatment emergent symptoms scale","volume":"21","author":"NIMH","year":"1985","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.phymed.2016.10.013_bib0042","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1211\/0022357991772790","article-title":"Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds","volume":"51","author":"Paladini","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phymed.2016.10.013_bib0043","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jad.2011.03.027","article-title":"Two-year course of depressive and anxiety disorders: results from the Netherlands study of depression and anxiety (NESDA)","volume":"133","author":"Penninx","year":"2011","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.phymed.2016.10.013_bib0044","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0367-326X(02)00063-1","article-title":"Ethnopharmacy of the ethnic albanians (Arbereshe) of northern Basilicata","volume":"73","author":"Pieroni","year":"2002","journal-title":"Italy, Fitoterapia"},{"key":"10.1016\/j.phymed.2016.10.013_bib0045","series-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2016"},{"key":"10.1016\/j.phymed.2016.10.013_bib0046","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1017\/S0033291708003954","article-title":"Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder","volume":"39","author":"Ramsawh","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.phymed.2016.10.013_bib0047","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1517\/14656566.2015.1059424","article-title":"Pharmacological treatment for generalized anxiety disorder in adults: an update","volume":"16","author":"Reinhold","year":"2015","journal-title":"Expert Opin. Pharmacother"},{"key":"10.1016\/j.phymed.2016.10.013_bib0048","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4142\/jvs.2006.7.2.189","article-title":"Matricaria chamomilla CH12 decreases handling stress in Nelore calves","volume":"7","author":"Reis","year":"2006","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.phymed.2016.10.013_bib0049","first-page":"9","article-title":"Pharmacotherapy of generalized anxiety disorder","volume":"14","author":"Rickels","year":"2002","journal-title":"J. Clin. Psychiatry 63 Suppl"},{"key":"10.1016\/j.phymed.2016.10.013_bib0050","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/da.22433","article-title":"Influence of study design on treatment response in anxiety disorder clinical trials","volume":"32","author":"Rutherford","year":"2015","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.phymed.2016.10.013_bib0051","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jamapsychiatry.2014.1319","article-title":"Placebo response in antipsychotic clinical trials: a meta-analysis","volume":"71","author":"Rutherford","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0052","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000209348","article-title":"Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials","volume":"78","author":"Rutherford","year":"2009","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.phymed.2016.10.013_bib0053","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0973-7847.79103","article-title":"Chamomile (matricaria chamomilla l.): an overview","volume":"5","author":"Singh","year":"2011","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.phymed.2016.10.013_bib0054","first-page":"895","article-title":"Chamomile: a herbal medicine of the past with bright future","volume":"3","author":"Srivastava","year":"2010","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phymed.2016.10.013_bib0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.v63n0901","article-title":"Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder","volume":"63","author":"Stahl","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0056","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest\u2014non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.phymed.2016.10.013_bib0057","first-page":"9","article-title":"The effects of benzodiazepines on cognition","volume":"66","author":"Stewart","year":"2005","journal-title":"J. Clini. Psychiatry"},{"key":"10.1016\/j.phymed.2016.10.013_bib0058","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2006-958058","article-title":"Apigenin, a component of matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects","volume":"61","author":"Viola","year":"1995","journal-title":"Planta. Med."},{"key":"10.1016\/j.phymed.2016.10.013_bib0059","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0378-5122(92)90117-M","article-title":"Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women","volume":"14","author":"Wiklund","year":"1992","journal-title":"Maturitas"},{"key":"10.1016\/j.phymed.2016.10.013_bib0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.phymed.2016.10.013_bib0061","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1248\/bpb.19.1244","article-title":"Effect of inhalation of chamomile oil vapour on plasma ACTH level in ovariectomized-rat under restriction stress","volume":"19","author":"Yamada","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2016.10.013_bib0062","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/da.10106","article-title":"Chronicity, relapse, and illness\u2013course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up","volume":"17","author":"Yonkers","year":"2003","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.phymed.2016.10.013_bib0063","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/S0367-326X(00)00186-6","article-title":"Behavioral characterisation of the flavonoids apigenin and chrysin","volume":"1","author":"Zanoli","year":"2000","journal-title":"Fitoterapia 71 Suppl"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711316301891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711316301891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T20:01:35Z","timestamp":1568491295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711316301891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":65,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0944711316301891"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2016.10.013","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2016.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}